Let's Make a Bet: You Prove the Markets are Rigged, and I'll Give you $10,000

Fausto Pugliese |

10000_USD_note__series_of_1934__obverse.jpg

An attendee of one of my recent webinars attempted to challenge some of my assertions about high frequency trading. He wrote me a very lengthy email that I will summarize here.



Basically, this gentleman was saying that market makers and other savvy institutional traders place very large false sell limit orders that are visible in Nasdaq Level II and Totalview in order to hold down stock prices while they accumulate shares. After accumulating the intended number of shares, they “lift” or cancel their false sell order and the stock takes off, giving them instant gains. This also occurs to the downside, where institutional traders place a large fake buy limit order in a stock that they intend to short, which allows them to keep building their short position. When they achieve their desired short position, these traders then cancel their false buy order, and the stock plunges.

While there is definitely truth to this gentleman’s assertion, he insists that these manipulative orders are actually “fake” orders, but I explained to him that these orders are very real. If you or any other trader attempts to execute these orders, they will get filled. Even though the market makers don’t intend for these manipulative orders to be executed, they are still on the hook to execute these orders if need be.

A More Than Decent Proposal 

To prove my point, I made him a bet: if he attempts to “hit” one of these so-called fake orders and the order actually proves to be fake, I will give him $10,000. If he was wrong and I was right, however, he has to pay only $29 for a one-week subscription to our CyberGroup chat room. Talk about a great proposition! Despite this, the gentleman never even answered my challenge. If he believed so strongly that these orders were actually fake, why wouldn’t he take my $10,000?!

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets

CF0005, LLC dba Mesa-Marshall #1-2

MESA Resources, Inc. ("MESA") is sponsoring the development of the oil & gas well completion project "Mesa-Marshall #1-2". MESA, founded in 1992, is engaged in the acquisition, exploration and development…

Quants Inc

Quants, Inc, a California Corporation, develops, markets and operates financial technology platforms and alternative investment products offering sophisticated risk management since 2010. The Company has primarily sharpened its focus with…